Eastman Chemical (EMN) Valuation: Is the Recent Downtrend Creating Opportunity for Investors?

Eastman Chemical (EMN) shares have drifted lower over the past month, with the stock trading down around 5%. Despite the muted price action recently, the company’s fundamentals and long-term positioning remain worth watching.

See our latest analysis for Eastman Chemical.

Eastman Chemical’s share price has had a rough time lately, continuing a downtrend that has lasted most of this year. While the stock rebounded 5.6% in a single day recently, its year-to-date share price return is a steep -32.8%, and the total shareholder return over the past year sits at -41.3%. Momentum is clearly fading in the near term despite underlying improvements in company fundamentals.

If you’re looking to discover what else is moving beyond big names in chemicals, now’s a great time to broaden your investing universe and uncover fast growing stocks with high insider ownership.

With Eastman Chemical trading well below analyst targets and sporting a nearly 50 percent discount to intrinsic valuation, investors have to ask whether bearish sentiment has gone too far or if the market is already anticipating a slow-growth future.

Most Popular Narrative: 18.5% Undervalued

Eastman Chemical's most widely followed narrative sees a fair value of $73.06, noticeably above the last close of $59.53. The sizable gap owes much to the way analysts are weighing longer-term profit improvement and post-downturn recovery.

Implementation of cost reduction initiatives ($75M-$100M in ongoing savings), strategic asset optimization (such as the ethylene to propylene project), and disciplined portfolio management is likely to lead to improving net margins and higher ROIC, especially as end-market demand recovers and utilization rates normalize.

Read the complete narrative.

Innovative projects and aggressive cost cuts are the backbone of this valuation. But what hidden assumptions about industry recovery rates and future earnings power are really steering this bullish outlook? Dig deeper to see the surprising drivers behind the calculated fair value.

Result: Fair Value of $73.06 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent global trade tensions and weak demand in key end markets could quickly undermine Eastman Chemical's recovery narrative and put pressure on future earnings.

Find out about the key risks to this Eastman Chemical narrative.

Build Your Own Eastman Chemical Narrative

Feel free to dive into the details and challenge these perspectives. Anyone can quickly create their own view in just a few minutes. Do it your way

A great starting point for your Eastman Chemical research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.

Looking for More Investment Ideas?

Don’t limit yourself to just one opportunity. Take the lead with new possibilities that could transform your portfolio and boost your long-term gains.

• Uncover overlooked potential by checking out these 3597 penny stocks with strong financials making waves in niche markets before the crowd catches on.
• Capitalize on tomorrow’s growth by reviewing these 926 undervalued stocks based on cash flows trading at attractive prices with room to reward patient investors.
• Get ahead of the healthcare revolution by evaluating these 30 healthcare AI stocks at the intersection of medical innovation and artificial intelligence.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com